EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release

Dimitra Tzavara, Konstantina Papadia, Argiris Kolokithas-Ntoukas iD, Sophia G Antimisiaris iD, Athanasios Skouras iD

Molecules · 28.06.2025 · 30 (13) · 2785

DOI: 10.3390/molecules30132785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 28.06.2025. Verfasst von Dimitra Tzavara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Rio Patras, Greece. Hauptthemen laut MEDLINE: Doxorubicin, Magnetite Nanoparticles, Acrylic Resins, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nanomedicine approaches for cancer therapy face significant challenges, including a poor tumor accumulation, limited therapeutic efficacy, and systemic toxicity. We hypothesized that controlling the clustering of poly(acrylic acid-co-maleic acid) (PAM)-coated superparamagnetic iron oxide nanoparticles (SPIONs) would enhance their magnetic properties for improved targeting, while enabling a pH-responsive drug release in tumor microenvironments.

Methods

PAM-stabilized SPION clusters were synthesized via arrested precipitation, characterized for physicochemical and magnetic properties, and evaluated for doxorubicin loading and pH-dependent release. A dual targeting approach combining antibody conjugation with magnetic guidance was assessed in cellular models, including a novel alternating magnetic field (AMF) pre-treatment protocol.

Results

PAM-SPION clusters demonstrated controlled size distributions (60–100 nm), excellent colloidal stability, and enhanced magnetic properties, particularly for larger crystallites (13 nm). The formulations exhibited a pH-responsive drug release (8.5% at pH 7.4 vs. 14.3% at pH 6.5) and a significant enhancement of AMF-triggered release (17.5%). The dual targeting approach achieved an 8-fold increased cellular uptake compared to non-targeted formulations. Most notably, the novel AMF pre-treatment protocol demonstrated an 87% improved therapeutic efficacy compared to conventional post-treatment applications.

Conclusions

The integration of targeting antibodies, magnetic guidance, and a pH-responsive PAM coating creates a versatile theranostic platform with significantly enhanced drug delivery capabilities. The unexpected synergistic effect of the AMF pre-treatment represents a promising new approach for improving the therapeutic efficacy of nanoparticle-based cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinMagnetite NanoparticlesAcrylic ResinsNeoplasmsMagnetic Iron Oxide NanoparticlesMaleatesHydrogen-Ion ConcentrationHumansDrug LiberationDrug Delivery SystemsCell Line, TumorDrug Carriers

Stichwörter der Autor:innen

alternating magnetic fieldcancer therapydrug deliveryhyperthermiamagnetic targetingpH-responsivesuperparamagnetic iron oxide nanoparticlestheranostic

Substanzen

Doxorubicincarbopol 940Magnetite NanoparticlesAcrylic ResinsMaleatesDrug Carriers

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Rio Patras, Greece.
  • Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, 779 00 Olomouc, Czech Republic.
  • Institute of Chemical Engineering Sciences, Foundation for Research and Technology Hellas (FORTH/ICES), 26504 Rio Patras, Greece.

ORCID-Profile: Argiris Kolokithas-Ntoukas, Sophia G Antimisiaris, Athanasios Skouras

Zitieren

APA

Tzavara, D., Papadia, K., Kolokithas-Ntoukas, A., Antimisiaris, S. G., & Skouras, A. (2025). Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release. Molecules, 30(13), 2785. https://doi.org/10.3390/molecules30132785

Vancouver

Tzavara D, Papadia K, Kolokithas-Ntoukas A, Antimisiaris SG, Skouras A. Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release. Molecules. 2025;30(13):2785. doi:10.3390/molecules30132785

BibTeX
@article{Tzavara2025,
  author = {Tzavara, Dimitra and Papadia, Konstantina and Kolokithas-Ntoukas, Argiris and Antimisiaris, Sophia G and Skouras, Athanasios},
  title = {Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {13},
  pages = {2785},
  doi = {10.3390/molecules30132785}
}
Kostenlos starten →